ARTICLES BY ERIC LARSON
Medtech Material Selection For Performance And Feel
When designing a medical device, material selection can be difficult, especially with thousands of plastic material options available. While material properties, environmental effects, regulatory requirements, and cost almost always are considered, "feel" is often overlooked – despite its importance to user and patient satisfaction, as well as market success.
Continue Reading..
Medical Plastics: Material Selection Based On Feel
From prioritizing material properties to establishing desired values for each property, selecting plastic materials based on feel is a complicated undertaking. To elicit the most desirable user response from the device, it can be helpful to consider the what, rather than the how.
Continue Reading..
Accumold Achieves ISO 13485 Recertification, Reaffirming Commitment To Precision In Medical Micro Molding
Accumold secures ISO 13485 recertification, reinforcing its commitment to precision, quality, and reliability in micro molded components for demanding medical device applications worldwide.
Continue Reading..
11.24.25 -- Don't Overlook These Tubing Resources…
11/24/25 Med Device Online Newsletter
Continue Reading..
11.23.25 -- Building World-Class Global Quality Teams That Break Down Silos
11/23/25 Med Device Online Newsletter
Continue Reading..
11.20.25 -- Jumpstart Your Product Development: Strategies For Success
11/20/25 Med Device Online Newsletter
Continue Reading..
11.19.25 -- Additive Manufacturing Meets Micro-Molding
11/19/25 Med Device Online Newsletter
Continue Reading..
11.19.25 -- Innovations Driving Medical Device Success
11/19/25 Med Device Online Newsletter
Continue Reading..
How MedTech And Pharma Are Responding To Rising R&D Pressures
MedTech accelerates innovation through acquisition and integration while pharma sustains research depth by distributing risk and cost. These distinct paths are reshaping product development.
Continue Reading..
ISO/DIS 10993-3 Updates: A Focus On DART For Medical Devices
Revisions to ISO 10993-1 and -3 emphasize a risk-based approach, lifecycle considerations, and a shift from biological testing to comprehensive evaluation for endpoints, impacting testing requirements.
Continue Reading..